Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Open to Accrual
Evaluate the success of targeting a carboplatin AUC with our current approach to dosing carboplatin.
Any patients who will receive treatment with intravenous carboplatin (any AUC, any cycle) on an NCI-sponsored NCTN-, ETCTN-, trial, local trial, or through standard of care.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.